Plastic surgery board certification advertising — ABPS, ASPS, ABMS, state medical board rules and the board-certified language distinctions

The ABMS Member Board framework — the structural anchor

The American Board of Medical Specialties, founded in 1933, is the not-for-profit organisation that recognises the primary certifying boards of medical specialties in the United States. It has 24 Member Boards covering the traditional medical specialties. Certification by an ABMS Member Board is the reference standard that state medical boards, hospitals, insurers and courts use when the phrase "board-certified" is at issue.

Plastic surgery is one of the 24 ABMS-recognised specialties, certified by the American Board of Plastic Surgery. Related aesthetic-adjacent ABMS Member Boards include the American Board of Dermatology, the American Board of Otolaryngology-Head and Neck Surgery (which certifies facial plastic surgeons trained through otolaryngology residencies via a subspecialty pathway), the American Board of Ophthalmology (which certifies ophthalmologists trained in oculoplastic surgery via a subspecialty pathway), and the American Board of Surgery (which certifies general surgeons).

On the osteopathic side, the American Osteopathic Association Bureau of Osteopathic Specialists (AOABOS) certifies DO physicians in equivalent specialties, and its certifications are treated as equivalent to ABMS certifications by most state medical board advertising rules.

Self-designated boards

A number of private certification organisations exist alongside the ABMS/AOA framework. The American Board of Cosmetic Surgery (ABCS) certifies physicians in cosmetic surgery — a specialty that does not exist as an ABMS-recognised primary certification. The American Board of Facial Plastic and Reconstructive Surgery (ABFPRS) certifies facial plastic surgeons whose primary residency is often otolaryngology or plastic surgery. These self-designated boards each have their own certification requirements and their own advertising expectations, but the state-level rules on what can be said in an advertisement using the phrase "board-certified" are largely written to reference the ABMS/AOA framework.

Board-certified, board-eligible, certified-by and "diplomate" — the terms in practical use

"Board-certified"

The strongest claim. Reserved by most state rules for physicians who have completed all requirements of and been granted certification by an ABMS Member Board, an AOA equivalent, or a specifically state-approved board. Use the exact board's name — "board-certified in plastic surgery by the American Board of Plastic Surgery" — rather than the generic phrase alone.

"Board-eligible"

Historically used to describe a physician who has completed residency and is in the process of certifying. State medical boards and ABMS itself have moved against unqualified use. ABMS Member Boards define time-limited eligibility windows after which a physician is no longer "eligible" without additional steps. Advertising as "board-eligible" without specifying the board and the eligibility status is increasingly treated as misleading.

"Diplomate"

Formal ABMS/AOA usage. A physician certified by a board is a "diplomate" of that board. This term is technically accurate and is generally permitted in advertising when accompanied by the board name.

"Certified by"

The phrase "certified by [specific board]" is generally acceptable across state rules when the specific board is a real certifying organisation, because the disclosure is precise and does not use the reserved unqualified phrase. If the board is not ABMS-recognised, a disclosure to that effect may be required in some states.

"Specialist in" and "focuses on"

These experience-based descriptions are broadly permitted. They must be accurate — a physician who does not concentrate their practice in cosmetic surgery cannot claim to focus on it — and they must not create the impression of a formal specialty certification the physician does not hold.

Where FTC Section 5 and FDA overlap the board-certification story

Section 5 of the FTC Act prohibits unfair or deceptive acts or practices. A physician who advertises a specialty certification they do not hold, or who uses the phrase "board-certified" in a state where the phrase is reserved for ABMS-recognised boards, is exposed to a Section 5 deception claim in addition to state medical board discipline. The FTC has historically deferred to state medical boards on physician advertising matters, but the deception framework applies as an alternative pathway.

The FDA layer arises when board-certification claims are combined with product promotion — a physician who advertises as "board-certified" while promoting an off-label injectable use in a manufacturer-affiliated campaign attracts the off-label promotion framework in addition. The layers combine — nothing is displaced.

Typical enforcement patterns for advertising misstatements

Enforcement is layered. State medical boards act on licensees; the FTC acts on advertisers; specialty societies act on members; state attorneys general act under UDAP. A single misleading board-certification claim can trigger any or all of these simultaneously.

• State medical board citation. The most common outcome. Typically involves mandatory corrective advertising, continuing-education requirement, sometimes a fine, and a public disciplinary record.
• State medical board licence suspension. Reserved for repeated or wilful misstatements combined with other unprofessional conduct.
• FTC Section 5 consent order. Requires corrective communications, fencing-in provisions on future conduct, and reporting for a fixed number of years.
• Society discipline. ASPS Judicial Council or equivalent — private admonition through expulsion.
• State attorney general UDAP action. Civil penalties calibrated per violation, restitution to affected consumers, injunctive relief.
• Private civil action. Under state UDAP or common-law fraud, where a consumer relied on the misstatement.